Skip to main content

Table 4 Primary and secondary end point in the two studied groups

From: Early application of continuous positive airway pressure in COVID-19 patients at risk of obstructive sleep apnea

 

Non-CPAP group

(n = 40)

CPAP group

(n = 40)

p-value

Primary end point

 Survival n (%)

Inhospital mortality n (%)

23 (57.5)

17 (42.5)

32 (80)

8 (20)

0.03

Secondary end point

a. Duration of hospital stay

  Total duration

19.5a (10–41)

15a (7–38)

0.04

    < 14 days

12 (30%)

18 (45%)

0.09

    > 14–28

20 (50%)

20 (50%)

    > 28

8 (20%)

2 (5%)

b. Need for invasive ventilation n (%)

34 (85)

24 (60)

0.01

  1. Data are presented as numbers (percentage), Mediana (range)